Manufacture and In Vivo Support of Gene-Edited, Regulatory-like, T-Cells (edTreg) Using a Synthetic IL2 Receptor
Gene Uenishi(University of Wisconsin–Madison), Greg J. Cost, Dariusz Wodziak(Akebia Therapeutics (United States)), David J. Rawlings(Center for Infectious Disease Research), Karen Sommer, Luis Fernando Gamboa(University of Washington), Cade Ellis Ito, Keith Abe(Mammoth Biosciences (United States)), Laura E. Smith, Greg Boucher(Akebia Therapeutics (United States)), Andrew M. Scharenberg(CTI BioPharma (Italy)), Chester Jacobs, Simon Gebremeskel(FibroGen (United States)), Samantha J. Chin(Akebia Therapeutics (United States)), Troy R. Torgerson(Allen Institute for Immunology), Samuel E. West, Cornell Mallari, Noelle Dahl, Basha Stankovich(Akebia Therapeutics (United States)), Chandra Patel(Akebia Therapeutics (United States)), Karen Vo(Washington State University Spokane), Rangoli Aeran(Encore Pharmaceuticals (United States))
Cited by 0
Related Papers
ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology
|Nature|2001|897
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889